RANIBIZUMAB Adverse Event: Lung neoplasm malignant
RANIBIZUMAB Adverse Event: Lung neoplasm malignant is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: RANIBIZUMAB; Product category: Drug; Primary reaction: Lung neoplasm malignant.
| Primary drug | RANIBIZUMAB |
|---|---|
| Product category | Drug |
| Primary reaction | Lung neoplasm malignant |
| All reactions | Lung neoplasm malignant; Metastases to heart; Metastasis |
| Seriousness | Serious |
| Patient outcome | Fatal |
| Patient sex | Female |
| All drugs reported | RANIBIZUMAB; LOSARTAN; METFORMIN |
| Reporter country | CO |
| Reporter type | 5 |
| Report date | 20140313 |
| Report ID | 10005816 |
$299/mo
Try FDATracker →